IBSA Institut Biochimique, S.A. v. Teva Pharmaceuticals USA, Inc.

 
APPEAL NO.
19-2400
OP. BELOW
DCT
SUBJECT
Patent
AUTHOR
Prost

Question(s) Presented

“Where a non-English language foreign priority application is the best intrinsic evidence of the inventors’ understanding of claim scope, can the foreign priority application be discounted during claim construction due to minor, irrelevant differences from the United States application?”

Posts About this Case